Literature DB >> 7761089

A temperature sensitive mutant of the human p53, Val138, arrests rat cell growth without induced expression of cip1/waf1/sdi1 after temperature shift-down.

Y Hirano1, K Yamato, N Tsuchida.   

Abstract

To investigate functions of wild type p53 in human cells, we introduced a (Ala-->Val) mutation at the 138th codon of the human p53 (Val138), which corresponds to the Val135 mutation of the temperature sensitive mouse p53. The human Val138 mutant showed temperature-sensitive transformation of rat embryo fibroblasts (REFs) in collaboration assay with activated ras, and arrested cell proliferation of transformed clones in G1 at 32.5 degrees C. Transient CAT assay for transcriptional activation in human Saos2 cells revealed activity equivalent to that of wild type at 32.5 degrees C but undetectable at 37.5 degrees C. These results suggest that the human Val138 mutant also exhibited the wild type phenotype at the permissive temperature as is for the mouse Val135 mutant, although we observed differences between the two mutants such as in transactivational activities in CV-1 and HeLa cells. Further, the role of cip1/waf1/sdi1 in the cell growth arrest of the Val138/ras-transformed REFs and Val138-introduced Saos2 cells was studied by northern hybridization analysis. Although rapid induction of cip1/waf1/sdi1 mRNA was observed in the Saos2 cells, no detectable induction of mRNAs for cip1/waf1/sdi1 and gadd45 was observed in the transformed REFs upon temperature shift-down, while mdm2 mRNA was enhanced, suggesting that the p53 gene could arrest cell growth by a mechanism other than that with induced expression of the gene for p21 cdk-cycline inhibitor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7761089

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells.

Authors:  G F Sullivan; J M Yang; A Vassil; J Yang; J Bash-Babula; W N Hait
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 2.  The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis.

Authors:  E Yonish-Rouach
Journal:  Experientia       Date:  1996-10-31

3.  Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma.

Authors:  Oreste Gallo; Nicola Schiavone; Laura Papucci; Iacopo Sardi; Lucia Magnelli; Alessandro Franchi; Emanuela Masini; Sergio Capaccioli
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

4.  Rapid profiling of disease alleles using a tunable reporter of protein misfolding.

Authors:  Adrianne M C Pittman; Melissa D Lage; Vladimir Poltoratsky; Justin D Vrana; Alessandro Paiardini; Alessandro Roncador; Barbara Cellini; Robert M Hughes; Chandra L Tucker
Journal:  Genetics       Date:  2012-08-24       Impact factor: 4.562

5.  Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.

Authors:  S Rowan; R L Ludwig; Y Haupt; S Bates; X Lu; M Oren; K H Vousden
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

6.  The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products.

Authors:  S T Wen; P K Jackson; R A Van Etten
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

7.  Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells.

Authors:  Juan Liu; Hiroshi Uematsu; Nobuo Tsuchida; Masa-Aki Ikeda
Journal:  Mol Cancer       Date:  2011-07-31       Impact factor: 27.401

8.  Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.

Authors:  N Veldhoen; J Watterson; M Brash; J Milner
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.